2 Quantum Computing Stocks With as Much as 162% and 197% Upside, According to Certain Wall Street Analysts

Analysts' highest price targets imply up to 162% upside for Rigetti and 197% for IonQ, despite shares being down ~32% and ~28% YTD respectively. Rigetti plans a 108‑qubit system by end of Q1 with two‑qubit gate fidelity of 99% and generates minimal revenue with hundreds of millions in losses; TipRanks shows 8 buys and 2 holds in recent coverage and Mizuho's top target is $43. IonQ reported a world‑record two‑qubit fidelity >99.99%, targets a 256‑qubit demo this year, posted $130M revenue in 2025 (+200% YoY) and holds ~$2.4B cash, with TipRanks‑cited analyst sentiment skewing bullish and Rosenblatt at a $100 target. Both stocks remain high‑volatility, speculative bets on quantum commercialization; position sizes should be small.

Analysis

The current market narrative prices quantum exposure as a binary commercialization bet where near-term technical milestones drive multi-quarter volatility rather than steady cashflow improvement. That structure creates asymmetric payoff windows around demos, partnerships and government procurement cycles: a successful commercial contract or cloud integration should compress perceived timeline risk and re-rate equities quickly, while missed milestones or dilution can induce >50% downside in short order.

Second-order beneficiaries are the niche supply chain vendors that scale with device count and deployment — low-noise control electronics, cryo/photonic subsystem suppliers, calibration and testing firms, and cloud integrators who bundle quantum-as-a-service. These firms can see durable revenue capture earlier than hardware vendors, creating opportunities for upstream suppliers to compound revenues even if a given hardware vendor stumbles.

Key tail risks are timeline slippage on error-correction scaling, a wider-than-expected classical algorithmic counterattack, and capital markets tightening that forces dilutive financings into event windows. Monitor three near-term binary catalysts — independent benchmarks, announced multi-enterprise pilots, and official procurement contracts — each able to rerate sentiment within a 3–12 month horizon; absence of positive news across two of those windows should materially compress upside expectations.

Key Decisions for Investors

• Long IONQ 18-month LEAP calls (allocate 0.5–1% portfolio). Thesis: buy optionality on commercialization inflection with limited cash exposure; target 2.5x on a successful commercial win within 6–12 months. Risk control: sell into 2x or set a hard stop at 40% loss from cost.
• Speculative RGTI equity + protective puts (allocate 0.25–0.5% equity, buy 6-month OTM puts). Thesis: capture outsized upside if product roadmap attracts partners while limiting downside to put premium; reward >3x if catalyst occurs. Risk control: roll puts or exit on dilution announcements or missed milestone confirmations.
• Event/vol trade: sell 30–60 day call spreads vs buy 90–180 day call spreads on IONQ (calendar call spread) sized to net collect premium but preserve upside exposure into tangible partnership announcements. Thesis: monetizes elevated implied vol ahead of demos while keeping directional upside; targeted return 1.5–2x premium with max loss defined by spread width.